Clinical Trial Update: Use of Somatropin in Turner Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating somatropin in Turner syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Turner Syndrome

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Genetic Disorder, Turner Syndrome | Phase 3 | Status: COMPLETED